TrivarX Limited (MDBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0025
-0.0132 (-84.08%)
At close: Jan 6, 2026
TrivarX Revenue
In the fiscal year ending June 30, 2025, TrivarX had annual revenue of 1.03M AUD with 16.00% growth. TrivarX had revenue of -97.63K in the half year ending June 30, 2025.
Revenue
1.03M AUD
Revenue Growth
+16.00%
P/S Ratio
37.53
Revenue / Employee
171.85K AUD
Employees
6
Market Cap
25.37M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.03M | 142.24K | 16.00% |
| Jun 30, 2024 | 888.83K | -71.62K | -7.46% |
| Jun 30, 2023 | 960.45K | -45.00K | -4.48% |
| Jun 30, 2022 | 1.01M | -258.10K | -20.43% |
| Jun 30, 2021 | 1.26M | 338.28K | 36.56% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |